Premises for Cholecystokinin and Gastrin Peptides in Diabetes Therapy

Clinical Medicine Insights: Endocrinology and Diabetes- United Kingdom

doi 10.1177/1179551419883608

Full Text

Abstract

Available in

Categories

Internal Medicine

Date

January 1, 2019

Authors

Publisher

SAGE Publications

Related search

Inter- And Intraspecies Polymorphisms in the Cholecystokinin-B/Gastrin Receptor Alter Drug Efficacy

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Cholecystokinin-B/Gastrin Receptors Enhance Wound Healing in the Rat Gastric Mucosa

Journal of Clinical Investigation

English

New 1,4-Benzodiazepin-2-One Derivatives as Gastrin/Cholecystokinin-B Antagonists.

Chemical and Pharmaceutical Bulletin

English

Involvement of Central Gastrin and Cholecystokinin in the Regulation of Food Intake in the Neonatal Chick

Journal of Applied Animal Research

English

Synthesis of Constrained Analogues of Cholecystokinin/Opioid Chimeric Peptides

Tetrahedron Letters

Organic Chemistry

English

Expression of Cholecystokinin-2/Gastrin Receptor in the Murine Pancreas Modulates Cell Adhesion and Cell Differentiation in Vivo

American Journal of Pathology

Forensic Medicine

English

Synthesis of Phenoxyacetic Acid Derivatives as Highly Potent Antagonists of Gastrin/Cholecystokinin-B Receptors.

Chemical and Pharmaceutical Bulletin

English

Radiolabeled Regulatory Peptides for Imaging and Therapy

Current Opinion in Endocrinology, Diabetes and Obesity

Internal Medicine

English

Antagonistic Effect of YM022, an Antiulcer Agent in Rats, on Human Cholecystokinin (CCK)B/Gastrin Receptor.

The Japanese Journal of Pharmacology

English